Replies to post #1375 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Incidentally, today’s SIGA news (up 130% today) makes it clear why SIGA nixed the merger with PharmAthene.

[ThomasS]

I wouldn't take it lightly... I think this product has legs.
up to $213 Million so far.

Should be able to perhaps bypass normal regulatory channels, i.e., "animal rule."

Huge market if successful. At least the US Gov't thinks so. And, they are located in the correct geographical region.